Understanding Paradox of Risk Factors



Fig. 27.1
Survival rate after intracerebral hemorrhage. Kaplan-Meier curves showing mortality over 4 years of follow-up. Reproduced by permission of Neurology [14]




Table 27.1
Potential reasons for the obesity-stroke paradox



















A. Protective cytokines

B. Greater metabolic reservoirs

C. Increased muscle mass

D. Nonpurposeful weight loss meaning cachexia

E. Attenuated response to renin-angiotensin-aldosterone system

F. Earlier symptom detection due to better medical consciousness

G. Inadequate measure of body composition


Reproduced by permission of JACC: Heart Failure [12]


A421200_1_En_27_Fig2_HTML.gif


Fig. 27.2
Multiple biases in obesity-stroke paradox



Conclusion

In conclusion, although researches exploring this interesting paradox have been emerged in multiple disease categories, the exact patho-mechanisms were not still identified yet. While the “paradox in stroke” seems to be a fascinating hypothesis, it might be a mere epiphenomenon or a transitional process toward disastrous clinical outcomes. Therefore, in considering unconfirmed limitations, physicians should carefully apply this hypothesis until more research is accumulated.


Suggestions from Current Clinical Practice Guidelines

It is strongly recommended that active or passive smoking should be avoided in stroke patients. Regarding alcohol drinking, drinking greater than two drinks per day should be avoided. In terms of obesity, beneficial impact of weight reduction in obese stroke patients has not been explored, but weight reduction is still being recommended in body mass index ≥ 25 mg/m2.



References



1.

Grines CL, Topol EJ, O’Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 1995;91:298–303.CrossrefPubMed


2.

Kirtane AJ, Martinezclark P, Rahman AM, et al. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:321–3.CrossrefPubMed

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 17, 2017 | Posted by in NEUROLOGY | Comments Off on Understanding Paradox of Risk Factors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access